Would an Ebola Vaccine Move Regeneron Pharmaceuticals' Bottom Line?
Regeneron Pharmaceuticals has won a BARDA agreement to develop a potential vaccine for the Ebola virus. How big of a deal is it for Regeneron investors today?
Clinton Proposals Could Spell Trouble for These 3 Drugmakers
An empowered Medicare program could pressure sales for GlaxoSmithKline, Merck, and Celgene.
3 Stocks We're Ready to Sell
When the market gets choppy, it can be a good time take a hard look at your portfolio.